Rossari Biotech Limited ROSSARI NSEINFRA
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it offers poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. Rossari Biotech Limited was founded in 1997 and is based in Mumbai, India.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Compounding revenue at 13.2% over 5 years.
- Profit CAGR of 11.6% over 5 years.
CONS
- Trading 30.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ROSSARI Rossari Biotech Limited NSEINFRA | 518.85 | 19.27 | ₹2,873.99 Cr | 0.10% | 15.41% | 11.85% | 13.22% | 11.63% |
| 2 | ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA | 11,482.00 | 41.32 | ₹3.38 L Cr | 0.67% | 11.90% | 10.59% | 12.40% | 17.26% |
| 3 | JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA | 1,278.00 | 14.01 | ₹3.12 L Cr | 0.56% | 19.15% | 27.26% | 3.61% | 75.28% |
| 4 | HINDZINC Hindustan Zinc Limited NSEINFRA | 632.95 | 19.34 | ₹2.67 L Cr | 3.32% | 62.35% | 76.94% | 5.61% | 9.58% |
| 5 | TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA | 208.02 | 28.34 | ₹2.59 L Cr | 1.92% | 11.32% | 11.16% | -1.59% | 7.21% |
| 6 | HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA | 1,126.70 | 18.73 | ₹2.52 L Cr | 0.44% | 9.50% | 10.29% | 7.40% | 9.87% |
| 7 | GRASIM Grasim Industries Limited NIFTY50NSEINFRA | 3,122.40 | 42.74 | ₹2.12 L Cr | 0.32% | 4.00% | 6.29% | 14.63% | -10.06% |
| 8 | SOLARINDS Solar Industries India Limited NSEINFRA | 18,247.00 | 98.04 | ₹1.65 L Cr | 0.06% | 29.51% | 31.33% | 13.27% | 30.36% |
| 9 | PIDILITIND Pidilite Industries Limited NSEINFRA | 1,482.80 | 61.73 | ₹1.51 L Cr | 0.67% | 28.48% | 23.52% | 7.50% | 24.36% |
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 512.73 Cr | 579.56 Cr | 543.72 Cr | 581.68 Cr | 684.86 Cr |
| Cost of Revenue | 350.05 Cr | 401.65 Cr | 371.35 Cr | 400.80 Cr | 495.72 Cr |
| Gross Profit | 162.68 Cr | 177.91 Cr | 172.37 Cr | 180.88 Cr | 189.14 Cr |
| Operating Expenses | 116.24 Cr | 126.64 Cr | 122.26 Cr | 131.62 Cr | 135.42 Cr |
| Operating Income | 46.44 Cr | 51.27 Cr | 50.11 Cr | 49.26 Cr | 53.72 Cr |
| EBITDA | 65.64 Cr | 71.43 Cr | 69.58 Cr | 69.78 Cr | 96.83 Cr |
| Interest Expense | 4.94 Cr | 5.50 Cr | 5.73 Cr | 7.67 Cr | 9.06 Cr |
| Pretax Income | 42.38 Cr | 47.71 Cr | 46.10 Cr | 42.50 Cr | 64.24 Cr |
| Tax Provision | 10.68 Cr | 13.26 Cr | 12.50 Cr | 9.73 Cr | 18.28 Cr |
| Net Income | 31.70 Cr | 34.44 Cr | 33.60 Cr | 32.77 Cr | 45.97 Cr |
| Diluted EPS | 5.72 | 6.21 | 6.06 | 5.91 | 8.29 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 1,651.32 Cr | 1,825.19 Cr | 2,080.29 Cr | 2,396.36 Cr |
| Cost of Revenue | - | 1,178.46 Cr | 1,304.07 Cr | 1,433.30 Cr | 1,668.73 Cr |
| Gross Profit | - | 472.86 Cr | 521.12 Cr | 647.00 Cr | 727.64 Cr |
| Operating Expenses | - | 321.23 Cr | 338.40 Cr | 448.99 Cr | 520.86 Cr |
| Operating Income | - | 151.63 Cr | 182.72 Cr | 198.01 Cr | 206.78 Cr |
| EBITDA | - | 229.47 Cr | 257.38 Cr | 270.07 Cr | 310.18 Cr |
| Interest Expense | - | 22.32 Cr | 19.37 Cr | 17.81 Cr | 28.54 Cr |
| Pretax Income | - | 144.22 Cr | 177.62 Cr | 185.19 Cr | 202.51 Cr |
| Tax Provision | - | 36.96 Cr | 46.93 Cr | 48.81 Cr | 53.30 Cr |
| Net Income | - | 107.26 Cr | 130.69 Cr | 136.38 Cr | 149.21 Cr |
| Diluted EPS | 17.70 | 19.38 | 23.62 | 24.63 | - |
Compounded Sales Growth
| 5 Years: | 13.22% |
| 1 Year: | 18.20% |
Compounded Profit Growth
| 5 Years: | 11.63% |
| 1 Year: | 33.50% |
Stock Price Performance
| 1 Year: | -22.67% |
| 6 Months: | -13.63% |
| 3 Months: | +1.95% |
| 1 Month: | +11.10% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 1,367.57 Cr | 1,572.15 Cr | 1,896.18 Cr | 2,288.79 Cr |
| Current Assets | - | 720.21 Cr | 843.58 Cr | 1,041.93 Cr | 1,235.90 Cr |
| Cash & Equivalents | - | 69.20 Cr | 25.17 Cr | 44.20 Cr | 75.31 Cr |
| Inventory | - | 188.48 Cr | 282.33 Cr | 355.08 Cr | 404.55 Cr |
| Receivables | - | 353.66 Cr | 425.13 Cr | 474.50 Cr | 557.41 Cr |
| Total Liabilities | - | 452.40 Cr | 524.42 Cr | 710.74 Cr | 955.44 Cr |
| Current Liabilities | - | 348.51 Cr | 424.74 Cr | 536.57 Cr | 789.56 Cr |
| Long Term Debt | - | 34.93 Cr | 33.32 Cr | 100.03 Cr | 94.33 Cr |
| Total Debt | - | 73.93 Cr | 118.79 Cr | 218.00 Cr | 435.94 Cr |
| Total Equity | - | 915.17 Cr | 1,047.73 Cr | 1,185.45 Cr | 1,333.35 Cr |
| Shares Outstanding | - | 5.52 Cr | 5.52 Cr | 5.54 Cr | 5.54 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 151.56 Cr | 43.26 Cr | 137.44 Cr | 65.07 Cr |
| Investing Cash Flow | - | -180.89 Cr | -103.21 Cr | -183.69 Cr | -219.48 Cr |
| Financing Cash Flow | - | 60.85 Cr | 16.18 Cr | 64.90 Cr | 186.32 Cr |
| Capital Expenditure | - | -32.88 Cr | -131.28 Cr | -158.51 Cr | -264.67 Cr |
| Free Cash Flow | - | 118.68 Cr | -88.03 Cr | -21.07 Cr | -199.60 Cr |
| Net Change in Cash | - | 31.52 Cr | -43.77 Cr | 18.65 Cr | 31.91 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 28.6% | 28.6% | 31.1% | 30.4% |
| Operating Margin % | - | 9.2% | 10.0% | 9.5% | 8.6% |
| Net Margin % | - | 6.5% | 7.2% | 6.6% | 6.2% |
| ROE % | - | 11.7% | 12.5% | 11.5% | 11.2% |
| ROCE % | - | 14.9% | 15.9% | 14.6% | 13.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ROSSARI